#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Muscular dystrophy Thalassaemia beta Fungal infection Propionic acidaemia Richter's syndrome Breast angiosarcoma Kaposi's sarcoma Adenomatous polyposis coli Glomerulonephritis membranous Cushing's syndrome Lupus nephritis White matter lesion Gastrointestinal disorder Myocarditis Osteosarcoma metastatic More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Life with Disease Rosai-Dorfman syndrome – Treatment Myxofibrosarcoma – Diagnostics Osteosarcoma – Basic Information Mantle cell lymphoma – Basic Information Lymphangioma – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Toxic epidermal necrolysis – Basic Information Pleural mesothelioma malignant Mantle cell lymphoma stage III – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Berotralstat Gadoxetic Acid, Disodium Syn2 Interleukin-1 Allo-501A Pegfilgrastim Granisetron Cloxacillin Mavorixafor HAFNIUM OXIDE Streptococcus Agalactiae Tovorafenib Brodalumab SELTOREXANT GRAPHITE Calcium Levofolinate Rly-4008 Netupitant Gliclazide Nebivolol Hydrochloride More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Neurogenic bladder Cholangiocarcinoma Breast cancer stage II Binge eating Autoimmune disorder Ulcerative keratitis Ewing's sarcoma recurrent Skin bacterial infection Generalised anxiety disorder Polycythaemia vera Type V hyperlipidaemia Antisynthetase syndrome Fallopian tube cancer stage IV Ovarian cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Relatlimab
    • Carboplatin
    • Cisplatin
    Austria Belgium Denmark France Germany Ireland +6

  • Study on the Effectiveness of Clostridium Botulinum Neurotoxin Type A for Reducing Wrinkles in Adults

    Recruiting

    4 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands

  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia
    • Neurodegenerative disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    Sweden

  • Study on the Effectiveness of Amoxicillin and Clavulanic Acid in Treating Chronic Wet Cough in Young Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cough
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    Norway

  • Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • DNL593
    • Famotidine
    Belgium Czechia France Italy The Netherlands Portugal +1

  • Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Upadacitinib
    Belgium Poland
Previous Page
1 … 186 187 188 189 190 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!